Clinical Trial Update: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial evaluating autologous CD6-CAR Treg cells in patients with Stage 3 Type 1 diabetes. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous CD6-CAR Treg cells (CD6-CAR regulatory T cells)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Stage 3 Type 1 Diabetes | EARLY_Phase 1 | Status: RECRUITING